50.60
+0.20
+(0.40%)
As of April 8 at 7:12:54 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 8 | 10 |
Avg. Estimate | 3.91B | 3.72B | 15.58B | 16.73B |
Low Estimate | 3.84B | 3.63B | 14.9B | 15.84B |
High Estimate | 4.01B | 3.85B | 16.24B | 18.05B |
Year Ago Sales | 3.63B | 3.49B | 14.46B | 15.58B |
Sales Growth (year/est) | 7.79% | 6.65% | 7.72% | 7.44% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0IC9.L | -- | -- | -- | -- |
S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
Downgrade | JP Morgan: Neutral to Underweight | 4/8/2025 |
Maintains | UBS: Neutral to Neutral | 3/21/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/20/2025 |
Maintains | JP Morgan: Neutral to Neutral | 3/11/2025 |
Maintains | Scotiabank: Sector Perform to Sector Perform | 12/12/2024 |
Maintains | Barclays: Overweight to Overweight | 10/15/2024 |